819 research outputs found
Scrofula Revisited: An Update on the Diagnosis and Management of Tuberculosis of Superficial Lymphnodes
Lymphnode tuberculosis is a disease of great antiquity. It is the commonest form of extra-pulmonary
tuberculosis, and is probably the commonest cause of chronic lymphadenitis in children. Even after the advent of
effective chemotherapy for tuberculosis, it still poses considerable problems in diagnosis and management. The
disease usually presents as a painless lymphadenopathy of the superficial lymphnodes of insidious onset, which
may proceed to abscess and sinus formation if neglected. Cervical nodes are most commonly affected, but multiple
node involvement is common. Differential diagnosis include other infections, neoplasia, congenital conditions in the
head and neck and rarely, drug reactions. Diagnosis, whenever feasible, should be made on the basis of histological
evidence after lymphnode biopsy. Diagnosis, made on clinical grounds has poor specificity and will result in a great
degree of over diagnosis. Recently, the role of fine needle aspiration cytology as an initial screening procedure has
been recognized. The Tuberculosis Research Centre carried out the first clinical trial which established the efficacy
of short course chemotherapy in the treatment of childhood lymphnode tuberculosis. In 168 children with biopsy
confirmed lymphnode tuberculosis treated with an intermittent six month regimen, the cure rate after five years was
95%. The Revised National Tuberculosis Control Programme recommends that patients with lymphnode tuberculosis
(Category 3) should be treated with rifampicin and isoniazid three times a week for six months, with pyrazinamide for
the first two months
Current trends in chemotherapy of tuberculosis
After treptomycin, which heralded the era of antibacterial chemotherapy for tuberculosis (TB),
many important advances have made available treatment regimens that are almost 100 per cent
curative. Randomised clinical trials by the Tuberculosis Research Centre, in Chennai and British
Medical Research Council in East Africa and in the Far East have helped to establish many of the
principles of antituberculosis chemotherapy. With successes have also come fresh challenges.
Mycobacterium tuberculosis becomes rapidly resistant to the drugs used against it and in the last
decade, the HIV epidemic has had an adverse impact on the global epidemiology of tuberculosis,
with many countries in Sub-Saharan Africa experiencing a 2-3 fold increase in their TB burden.
While the currently recommended treatment regimens are very effective, they have failed to control
the burden of TB in the developing countries due to less than satisfactory implementation of the
control programmes. Faced with the dual threat of multidrug resistant TB and the HIV/facilitated
increase in TB, the WHO has instituted a Global TB Control Programme based on the directly
observed treatment shortcourse (DOTS) strategy. Much of the principles of this strategy have
come out of research in India. As part of this strategy, the Government of India is implementing
a Revised National Tuberculosis Control Programme (RNTCP). Under the RNTCP standardized
treatment regimens are prescribed for different treatment categories. Already more than 80 per
cent of the population is covered by this Programme and full coverage is slated for 2005.
Meanwhile, fresh research is ongoing to shorten treatment duration, a measure that should
greatly aid TB control
Influence of a fish bacterium Lactobacillus sp. on the production of swordtail xiphophorus helleri (Heckel 1848)
The influence of a fish gut bacterium Lactobacillus sp on the production of swordtail Xiphophorus helleri was studied for a period of one year. The Lactobacillus sp P21 produced bacteriocin-like inhibitory substance and exhibited wide spectrum of action against Aeromonas hydrophila, Bacillus spp, Pseudomonas spp and Citrobacter freundi in vitro. The growth performance of X. helleri reared in the presence of Lactobacillus P21 at 106/ml rearing water was better than the control. The total plate counts, total MRS agar counts and the counts of motile aeromonads, presumptive pseudomonads, lactose fermenters and lactose non-fermenters in the gut of probiotic group were comparatively low than the control. On day 60 the count of Lactobacillus sp P21 was observed to be log 5.28/g in the gut of X. helleri indicating colonization of this bacterium in the gastrointestinal tract. The fecundity of X. helleri was in the range of 9-134. On average, it produced from 39.42±18.72 fry/female in control group to 53.00±23.57 fry/female in probiotic group. The increase in average fecundity in probiotic group over the control group was about 25%. There existed significant difference between probiotic group and control in respect of average fecundity/female (p<0.02), average number of fry survived /female (p<0.006) and average number of fry dead/female (p<0.029). The results of the present study demonstrated that the rearing of X. helleri in probiotic-enriched water have growth inducing ability and favourably influenced the reproductive performance in terms of high fecundity, high fry survival, reduced fry mortality and reduced fry deformity
Effects of dietary supplementation of commercial human probiotic and antibiotic on the growth rate and content of intestinal microflora in ornamental fishes
The effects of dietary supplementation of commercial human probiotic, Lactobacil and antibiotic, oxytetracycline on the growth, survival, disease resistance and content of intestinal microflora in two ornamental fishes, viz., goldfish, Carassius auratus and swordtail, Xiphophorus helleri were studied. The total wet weight gain, food conversion ratio and specific growth rate of C. auratus did not vary significantly (p>0.05) among treatments. While in X. helleri, significant differences existed in the total wet weight gain, survival, food conversion ratio and specific growth rate among treatment groups (p<0.05). The counts of antibiotic resistant bacteria in fish gut increased with days of culture in all the treatments and the increase was more in antibiotic fed fishes. A reduction in the development of antibiotic resistance among the bacterial flora of fish gut was noticed in probiotic fed groups of C auratus and X. helleri. The results of the present study revealed that the effects of human probiotic on the growth, survival and disease resistance of ornamental fishes are variable and difficult to reproduce the similar effect on different species
Rifampicin-induced renal toxicity during retreatment of patients with pulmonary tuberculosis
Rifampicin is a crucial component of treatment regimens for tuberculosis and has been in use since the early
1970’s. It is usually considered safe. Rarely life-threatening complications like acute renal failure or acute
thrombocytopaenia may manifest during treatment with rifampicin. In our experience at the Tuberculosis
Research Centre of treating more than 8000 pulmonary and extrapulmonary tuberculosis patients with
rifampicin-containing regimens over the last 30 years, we are reporting 3 cases of probably rifampicininduced
acute renal failure. Despite extreme therapeutic safety of this drug the clinician must be aware of this
rare complication, which if detected early is completely reversible
Role of Non-Governmental Organizations in Tuberculosis control
Our experience over the last 18 months has given us hope that NGOs have great potential as an effective task force in augmenting the efforts of the government in tuberculosis control activities. They have been successful in identifying and referring chest symptomatics to us. In the near future,we hope to test out strategies for utilising their services in case-holding and supervised administration of chemotherapy
hs-C-Reactive Protein in Chronic Renal Failure With and Without Cardiovascular Complications
In the present study a group of 42 newly detected CRF patients (28 males and 14 females) were selected and 10 normal individuals (5 males and 5 females) were selected as control group after careful application of inclusion
and exclusion criteria. They were subjected to detailed sociodemographic clinical and systemic examination and routine laboratory tests. The study subjects underwent ultrasonographic evaluation. A single time fasting blood
sample was obtained and hs-CRP assay was done. Then they underwent funduscopic and echocardiographic evaluation. The results obtained were statistically analysed using Epi info-2002. CRF patients are susceptible to cardiovascular morbidity and mortality.
Various risk factors have been identified in them. One another risk factors was elevated hsCRP the present study has made an attempt to find out hsCRP levels
in the selected CRF patients and correlate the levels with albuminuria, haemoglobin levels, severity of retinopathy and cardiovascular complications.
The hsCRP levels were significantly elevated in the CRF patients (Mean 1.22mg% SD ± 0.99mg%) than the control (Mean 0.08mg% SD ± 0.01mg%) and it was independent of age, gender and serum creatinine levels. However elevated hsCRP correlated with albuminuria, haemoglobin levels, severity of retinopathy and cardiovascular morbidity.
The hsCRP measurement may well prove an exception in view of its robustness, its relative stability in individuals over time, and most importantly its ability to add to the cardiovascular risk information. Areas for future research and recommendation were identified
- …